Toward Integrative Omics
Cancer is incredibly complex, posing enormous challenges beyond the biological field. Taking a multi-omic approach can help us make sense of this diverse set of diseases – and, ultimately, allow us to better understand ourselves as human beings.
Amanda Hummon |
I started researching colorectal cancer for multiple reasons, but a significant part of my interest was triggered by grief; a member of my immediate family died as a result of metastatic colorectal cancer, despite having the access to the best medical care. I wanted to understand more of what had happened and why.
Reading about colorectal cancer, it was apparent that while the genomics and transcriptomics of the disease had been well studied, the proteomic changes that accompany the disease were not as well understood. I believe the prejudice is related to the tools that were/are available to tackle the problem. After realizing how much remained to be done in the field of cancer proteomics, I decided to devote my career to studying the molecular changes that underwrite colorectal cancer. The more I work in this field, the more I recognize how truly deep understanding – from genotype to phenotype – is the only way we can tackle cancer.
Omics in the Literature
What does analysis of the last 15 years of literature on the different omics tell us about the growing importance of the field, and the move towards a more integrated approach?
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.